Peter B. Jahrling - Concepedia

Author

Peter B. Jahrling

United States Army Medical Research Institute of Infectious Diseases ORCID

Also Known As

Curtis, Kristopher M., Hagen, Katie R., Huggins, John W, Jahrling, Peter B., Jahrling,Peter B, Olinger, Gene G., P B Jahrling, P. B. Jahrling, P. Jahrling, P.B Jahrling

364

Publications

28.5K

Citations

H-Index

150

Concepts

All Affiliations

United States Army Medical Research Institute of Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health Centers for Disease Control and Prevention

About

Peter B. Jahrling is an author at United States Army Medical Research Institute of Infectious Diseases specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	65	151	16K
2	Natural Sciences	5	5	875
3	Engineering	4	4	394
4	Public Health	4	4	197
5	Health Sciences	3	3	123

Peter B. Jahrling

232

Publications

24.1K

Citations

H-Index

Page 1

	Year	Citations
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection Julie Dyall, Christopher M. Coleman, Brit J. Hart, Antimicrobial Agents and Chemotherapy Dopamine ReceptorViral DiagnosticsEmerging Infectious DiseasesNeurovirologyPharmacology	2014	695
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses Steven J.M. Jones, Heinz Feldmann, Ute Ströher, Nature Medicine VaccinationMarburg VirusesMucosal VaccinationVaccine DevelopmentVaccine Target	2005	679
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques Thomas W. Geisbert, Lisa E. Hensley, Howard A. Young, American Journal Of Pathology PathogenesisImmunologyVirologyCynomolgus MacaquesMedicine	2003	567
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin Nanhai G. Chen, Guiyun Li, M. Kathryn Liszewski, Virology Virus EpidemiologyMedicinePathogenesisMonkeypox Virus IsolatesEmergent Virus	2005	532
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates Nancy J. Sullivan, Thomas W. Geisbert, Joan B. Geisbert, Nature VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology	2003	461
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations Jens H. Kuhn, Stephan Becker, Hideki Ebihara, Archives of Virology PhylogeneticsFamily FiloviridaeNatural SciencesEvolutionary BiologyRevised Taxonomy	2010	458
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox Patricia L. Earl, Jeffrey L. Americo, Linda S. Wyatt, Nature VaccinationVaccine DevelopmentVaccine ResearchVaccine TargetImmunology	2004	457
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis Jason Kindrachuk, Britini L. Ork, Brit J. Hart, Antimicrobial Agents and Chemotherapy	2014	418
Preliminary report: isolation of Ebola virus from monkeys imported to USA Peter B. Jahrling, Thomas W. Geisbert, E. D. Johnson, The Lancet Virus EpidemiologyEmerging Infectious DiseasesPreliminary ReportVirologyDisease Outbreak	1990	392
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus Boyd L. Yount, Kristopher M. Curtis, Elizabeth A. Fritz, Proceedings of the National Academy of Sciences	2003	388

Page 1